Drug Approval | November 10, 2025
Glenmark secures China approval for Ryaltris
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
From material selection to cooling tower management, every small decision affects long-term equipment reliability
AI-powered cardiometabolic wellness platform for India’s workforce
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
The platform is being introduced to expand access to treatments for people living with chronic conditions
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Subscribe To Our Newsletter & Stay Updated
